Gamida Cell Ltd.
EXPANDED NK CELL FRACTIONS FOR TRANSPLANTATION IN COMBINATION THERAPY
Last updated:
Abstract:
Methods of expanding a natural killer (NK) cell fraction for transplantation into a subject are provided, and particularly, methods for providing transplantable NK cell fractions and protocols for their use, which can be employed for applications in cell transplants and infusions, in particular, in combination therapy with anti-CD20 anti-cancer antibodies for treatment of cancer and other disease.
Status:
Application
Type:
Utility
Filling date:
19 Mar 2020
Issue date:
11 Aug 2022